Company intelligence / Profile preview

Medicus Pharma Ltd.

Conshohocken / Philadelphia, Pennsylvania, United Statesmedicuspharma.com ↗

Ownership: Public · MDCX
Development stage: Other

Overview

Medicus Pharma’s lead program SkinJect has completed a successful Phase I trial demonstrating safety and preliminary efficacy for basal cell carcinoma. The ongoing randomized controlled Phase II trial has shown over a 60% clinical clearance rate at interim analysis. The company recently secured $7M in funding to support these trials and plans to expand its pipeline through acquisitions such as the announced deal with Antev Ltd., which brings late-stage programs targeting prostate cancer and acute urinary retention[6][7].

Therapeutic areas: Men's HealthOncology
Modalities: Small molecules (e.g., doxorubicin in microneedle array)Drug-device combination (dissolvable microneedle patch)Peptide-based GnRH antagonist (Teverelix, pending acquisition)
Industry: Biotech

Drug pipeline

2 assets

SkinJect Patch

1 more asset in the full pipeline.

Request access →

Partnerships

University of Pittsburgh & Carnegie Mellon University—patent holders/licensors of core technology used by SkinJect Inc.[4]

Financials

Market cap: $10.1M
Total revenue: $0
Enterprise value: $3.9M

Beyond the preview

Go deeper on Medicus Pharma Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicus Pharma Ltd..

Explore the full profile